NAD+: structure, nomenclature and handling

The molecule is built from two halves. One is adenosine monophosphate: adenine attached to a ribose sugar carrying a phosphate. The other is nicotinamide mononucleotide: a nicotinamide ring attached to its own ribose and phosphate. The two phosphates are joined to one another, forming a pyrophosphate bridge that holds the halves together — hence dinucleotide.

The plus sign denotes the oxidized state. The nicotinamide ring in this form carries a positive charge and is the reactive centre of the molecule: it can accept a hydride, converting NAD+ into the reduced form, NADH, and back again. That interconversion is the entire working identity of the compound — in vitro it serves as the electron-carrying cofactor for the large family of oxidoreductase enzymes, cycling between the two states as those enzymes run.

The free acid has a molecular weight of approximately 663 daltons. Because the oxidized and reduced forms are different chemical species with different stability profiles and different spectra, which one a vial contains is a substantive question, not a labelling nuance.

The systematic name is nicotinamide adenine dinucleotide, and the oxidized form is written NAD+ or beta-NAD. Older literature catalogues the same molecule as diphosphopyridine nucleotide, abbreviated DPN, and as coenzyme I — names worth recognising when comparing against decades-old references. The oxidized free acid carries CAS 53-84-9.

The reduced form, NADH, is a distinct catalogue entity, typically supplied as a disodium salt and carrying its own registry number. Listings and certificates should be read with the pair in mind: material described only as "NAD" without the charge state named is ambiguous in a way that the certificate resolves. The phosphorylated relatives NADP+ and NADPH are again separate compounds — one additional phosphate on the adenosine ribose — and not interchangeable with this one.

High-performance liquid chromatography resolves the main peak from related substances and yields the purity figure. The characteristic related substances for this compound are its own relatives: the reduced form, the hydrolysis products of the pyrophosphate bridge, and free nicotinamide released by ring degradation. All are chromatographically distinguishable from the intact oxidized dinucleotide.

Ultraviolet spectroscopy carries unusual importance here, because the two redox states announce themselves spectrally. Both forms absorb near 260 nanometres, where adenine absorbs; only the reduced form absorbs at 340 nanometres. A vial of the oxidized compound should therefore show essentially nothing at 340, and absorbance there quantifies contamination by the reduced form directly. Certificates for this class of compound often report spectral ratios for exactly this reason.

Mass spectrometry confirms the intact molecular mass near 663 daltons, distinguishing the dinucleotide from its cleavage fragments, which differ by large, defined increments.

HEEZ Research supplies NAD+ in a single format: a 500 mg lyophilized vial — by mass, the largest single-vial quantity in the catalogue, reflecting that cofactor work consumes material on a different scale from peptide work.

The material is supplied as a lyophilized powder. Freeze-drying removes water and leaves the compound as a solid, markedly more stable than the same compound in solution, and stable enough at ambient temperature to ship without refrigeration in transit.

At roughly 663 daltons this is a small molecule, so 500 mg represents a large molar quantity — a distinction that matters wherever protocols are specified in molar rather than mass terms.

Reconstitution converts the dried powder into a working solution, and it is a standard laboratory step rather than a product specification. Which solvent is used, and at what final concentration, is determined by the protocol in force at the receiving facility.

What HEEZ specifies is the contents of the vial: lyophilized NAD+ in a single 500 mg format, stated on the label and on the batch certificate of analysis. Where a protocol is expressed in molar rather than mass terms, the additional figure it needs is the molecular weight, which the certificate records for the batch supplied.

One property of the redox pair is worth knowing at the bench: the oxidized and reduced forms have opposite pH sensitivities. The oxidized form is the more stable of the two under mildly acidic conditions and degrades under alkaline ones; the reduced form inverts that pattern. Solutions of this compound are therefore not held at high pH, and the pairing means a stability observation made on one form does not transfer to the other.

Sealed lyophilized NAD+ is ambient-stable for the duration of transit, so no cold chain or insulated packaging is required for shipping. On receipt the vial goes to refrigeration and is kept out of direct light.

The solid is notably hygroscopic. Allowing a cold vial to reach room temperature before opening prevents atmospheric moisture condensing into the powder, and prompt resealing matters more for a 500 mg vial that will be opened repeatedly than it does for single-use peptide formats.

Solutions are made up as needed and held cold. The dissolved compound degrades faster than the solid by every route — hydrolysis of the pyrophosphate bridge and of the nicotinamide-ribose linkage among them — and repeated freeze-thaw cycling is avoided.

The certificate records what an independent facility measured for one specific batch. Its value lies in being batch-specific, so the first check is that the lot number on the document matches the vial in hand.

The identity section compares observed molecular mass against the theoretical figure for the free acid near 663 daltons, and confirms the material is the oxidized form rather than the reduced one — the spectral reading at 340 nanometres being the direct evidence on that point.

The purity figure is the HPLC main-peak area as a percentage of total peak area, and the attached chromatogram shows how that figure was arrived at. Peaks corresponding to free nicotinamide or cleavage fragments indicate degradation rather than synthesis error, which is a different problem with a different cause.

Content is sometimes reported against the anhydrous free acid, accounting for residual water and counter-ions — the figure that determines how much actual compound a nominal 500 mg represents, and a meaningful one for a hygroscopic solid.